Shares of SPT opened at $26.52 on Wednesday. The company has a debt-to-equity ratio of 0.19, a current ratio of 0.96 and a quick ratio of 0.96. Sprout Social has a 1 year low of $25.05 and a 1 ...

Itron (NASDAQ:ITRI – Get Free Report) had its price target lifted by analysts at Piper Sandler from $119.00 to $124.00 in a research note issued to investors on Thursday,Benzinga reports.

LMND opened at $36.17 on Wednesday. The stock has a 50-day moving average of $35.11 and a 200 day moving average of $29.37. Lemonade has a 12 month low of $14.03 and a 12 month high of $53.85. The ...

NASDAQ:JAZZ opened at $143.53 on Wednesday. The company has a 50 day moving average price of $126.28 and a 200-day moving average price of $118.79. Jazz Pharmaceuticals has a 1-year low of $99.06 ...

Piper Sandler upgraded shares of ZoomInfo Technologies (NASDAQ:ZI – Free Report) from an underweight rating to a neutral rating in a research note released on Wednesday morning, MarketBeat reports.

What does this Advisor Specialize in? Find a financial advisor who specializes in the area of expertise you require. It's important to find an advisor who can help you approach your personal and ...

The analyst team out of Piper Sandler upgraded shares of Mediterranean fast-casual restaurant Cava Group (CAVA) to Overweight. Julie Hyman and Josh Lipton highlight Cava's stock trajectory since ...

Piper Sandler upgraded CAVA Group (NYSE:CAVA) to an Overweight rating on Friday after having the restaurant stock slotted at Neutral. Analyst Brian Mullan and his team see CAVA (NYSE:CAVA ...

Investing.com -- Piper Sandler upgraded CAVA Group Inc (NYSE:CAVA) to “Overweight” from “Neutral” following a sharp pullback in its stock given strong fundamentals and long-term growth ...

Piper Sandler analyst Rob Owens raised the firm’s price target on Elastic (ESTC) to $135 from $130 and keeps an Overweight rating on the shares. Accelerating RPO and cloud growth were the ...

Piper Sandler analyst Matthew O’Brien maintained a Buy rating on TransMedics Group (TMDX – Research Report) today and set a price target of $90.00. The company’s shares closed yesterday at ...

In a report released today, Joseph Catanzaro from Piper Sandler maintained a Hold rating on Iovance Biotherapeutics (IOVA – Research Report), with a price target of $6.00. The company’s shares ...